ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
Clinical trial NCT02141451 · COMPLETED
Trial details
- NCT number
- NCT02141451
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2019-01-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.